Pancreatic Cancer Europe

PCE had the opportunity to interview Professor Chris Verslype, KU Leuven, Belgium. Interview with Professor Chris Verslype, KU Leuven, Belgium

PCE had the privilege to interview Chris Verslype, Dean of the Faculty of Medicine at KU Leuven, Belgium.

👉 Watch the full interview here:

PCE is pleased to launch the “Treatment Opportunities and Pancreatic Cancer” booklet.

A clear, accessible guide to help patients and carers navigate treatment options with confidence.

Download here: https://pancreaticcancereurope.eu/project/treatment-opportunities-for-pancreatic-cancer-project/

3️⃣ days to go! Join us on 27 Nov, 15:30–17:00 CET for our PCE & EPC webinar on clinical trials.

Opening Session Speakers: Ilse Rooman, Nicolás González Casares, Teresa Macarulla & Ingrid Garajova.

Register by 27 Nov, 12:00 CET: forms.gle/eeAuHddabv7z...

Over the past weeks, we’ve answered key questions about clinical trials—what they are, why they matter, who can join, and how they help current and future patients. For more clear, reliable information on pancreatic cancer clinical trials, visit: pancreaticcancereurope.eu/clinical-tri...

PCE is proudly participating in the European Cancer Summit 2025 this week, joining colleagues, partners, and leaders from across Europe to advance our shared mission of improving pancreatic cancer care and outcomes. @europeancancer.bsky.social

Thank you to the European Cancer Organisation for showcasing our project at the #EuropeanCancerSummit 2025!
Special thanks also to @pce-europe.bsky.social for participating at the event 💜

#pancreaticcancer #cancersummit

🟣Digestive Health Manifesto 👉https://eosnetwork.org/News/ueg-digestive-health-manifesto-2025
A call for stronger patient involvement in cancer care, PROMs & clinical trials.

🤝@myueg.bsky.social @digestivecancerseu.bsky.social @pce-europe.bsky.social

#digestivehealth #EUNewsline #EGID

PCE is proudly participating in the European Cancer Summit 2025 this week, joining colleagues, partners, and leaders from across Europe to advance our shared mission of improving pancreatic cancer care and outcomes. @europeancancer.bsky.social

In the afternoon sessions, we discuss work packages 1 – 3, first each progress separately, then jointly in a planum discussion.
1️⃣ Patient cohorts & sample collection
2️⃣ #liquidbiopsy diagnostis
3️⃣ AI analysis & data management

#PancSky

CT don’t just shape the future of cancer care, they can also make a difference today.

Today’s question: Can a trial help me now or only in the future?

Sometimes both! CT explore new treatments that may help patients receiving care, while also generating knowledge that benefits future patients.

Bonjour and goedendag from Brussels! Our 4th PANCAID General Assembly Meeting just kicked off with a masterclass shared by Klaus Pantel and Catherine Alix-Panabieres, on #Liquidbiopsy diagnostics

#pancreaticcancer
@cathiepana.bsky.social

We just had our PANCAID ECS session, where each ECS gave an update on their individual research projects.
Thank you to Ebba Asplund, Kim-Lea Reese, Robert Wittram, Pabolo Villoslada-Blanco, Sergio Sabroso and Mireia Andueza for your presentations and contributions!
#pancreaticcancer #earlydetection

This week in our World Pancreatic Cancer Awareness Month series on clinical trials, we’re looking at another important question patients often ask:

🔍 Do patients get help in a trial?

✅ Yes. Doctors and nurses take special care of people taking part in clinical trials to keep them safe.

Today, we’re moving to another important question many people have:

🔍 Are clinical trials safe?

Clinical trials follow strict regulations to protect participants.

Importantly, patients can stop taking part at any time if they wish.

Who can join a clinical trial? 🟣

People with cancer may join if they meet certain criteria like age, cancer type, stage & overall health.

Talk to your doctor to learn if a trial is right for you.

Who can join a clinical trial? 🟣

People with cancer may join if they meet certain criteria like age, cancer type, stage & overall health.

Talk to your doctor to learn if a trial is right for you.

Have you registered? PCE, in collaboration with the
European Pancreatic Club invites you to a webinar on how clinical trials are shaping the future of pancreatic cancer care.

🗓 27 Nov

🕞 15:30–17:00 CET

🔗 Register by 27 Nov, 12:00 CET: forms.gle/eeAuHddabv7z...

Why are clinical trials important in #PancreaticCancer?

Because every new treatment, every improved therapy, and every survival gain starts with a clinical trial. Without them, progress stops.

🔁 Please like, share or comment to raise awareness.

🟣 What is a clinical trial?

It’s a research study that tests new drugs or treatments to see if they are safe and effective. Every cancer treatment used today began as a clinical trial. Follow along this month as we answer more questions. 

#WorldPancreaticCancerMonth #ClinicalTrials #PCE

PCE took part in the 2nd Botton-Champalimaud International Pancreatic Cancer Conference from 29 October to 1 November.

Our Secretariat, Luisa Pagano, presented PCE’s work on patient advocacy and research support, and introduced our 10th Anniversary campaign.

📢 Continuing the Momentum for Pancreatic Cancer Across Europe

👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy

@digestivecancerseu.bsky.social @cancerpatientseu.bsky.social
​ @myueg.bsky.social
​

a blue and yellow flag with yellow stars

Together, we’re advancing pancreatic cancer care across Europe. 🌍

Since the #PancreaticCancer Position Paper was published in May 2024, we’ve been turning its recommendations into action – improving prevention, early detection & care.

👉 Learn more: https://bit.ly/3JzYNiC

#EUNewsline

Since the publication of the Pancreatic Cancer Across Europe Position Paper in May 2024, our partner organisations have continued working to turn its recommendations into tangible progress.

Read the full update on what has been achieved so far: shorturl.at/pod8H

November is Pancreatic Cancer Awareness Month, a time to raise awareness and take action. 💜 This year, we’re focusing on Clinical Trials 🔬, key to new treatments and hope for patients. Stay tuned for our Q&A series!

PCE proudly joins the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA) - Pancreatic Cancer Europe PCE is proud to announce its membership in the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA), a pioneering initiative that, for the first time, brings together leading Pancreatic Ductal Adenocarcinoma (PDAC) investigators from across the…   ...Read More »PCE proudly joins the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA)

PCE is proud to be a member of the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA), a pioneering initiative that unites leading experts from across the globe.

Learn more:

A pancreatic cancer diagnosis affects not only the body but also the mind. 🧠

Through our Emotional Support and Pancreatic Cancer Project, we aim to make mental health a core part of cancer care.

👉 Find useful resources here: pancreaticcancereurope.eu/project/emot...

Join us together with @cancerpatientseu.bsky.social on Tuesday, 14 October 2025, from 15:30 to 17:00 CET for the online webinar “The Role of EU HTA in National Healthcare: Bridging Policy and Patient Access.”

Find out more and register: pancreaticcancereurope.eu/project/the-...

Supporting @pce-europe.bsky.social during #UEGWeek @myueg.bsky.social

We were delighted to welcome Professor Matthias Löhr, President of @myueg.bsky.social
to the PCE booth during #uegweek 2025!

Thank you, Professor Löhr, for your continuous support and commitment to improving outcomes for people affected by pancreatic cancer. 💪💜